Latest filing published 31 Jul 2019 for Clovis Oncology, Inc., €6,731.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Paul H. Klingenstein: trading record in brief
Filings by Paul H. Klingenstein span 4 companies, the busiest being ReShape Lifesciences Inc., Histogen Inc. and Anacor Pharmaceuticals, Inc. Over a trading history stretching from 15 November 2007 to 29 July 2019, the count stands at 54 filings.
On the open market, the record shows 19 purchases worth €9.1M and 2 sales worth €4,694. Netting one side against the other leaves €9.1M of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants and 1 option exercise.
A typical purchase (the median) is worth €107k.
The record was last updated on 31 July 2019 with an option exercise (€6,731) in Clovis Oncology, Inc. The last purchase on record was published on 1 August 2013, which is 4,847 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Paul H. Klingenstein
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,862 shares@ US$0.29100.0% of flowCommon StockSEC:0000899243-19-020671:0
- 1,283,589 shares0Common StockSEC:0001209191-14-014153:0
- 30,216 shares0Common StockSEC:0001209191-14-014153:1
- 36,634 shares0Common StockSEC:0001209191-14-014153:2
- 36,634 shares0Common StockSEC:0001209191-14-014153:3
- 20,322 shares0Common StockSEC:0001209191-14-014153:4
- 8,731 shares0Common StockSEC:0001209191-14-014153:5
- 1,979,321 shares0Common StockSEC:0001209191-13-038814:0
- 46,594 shares0Common StockSEC:0001209191-13-038814:5
- 728,239 sharesCommon StockSEC:0001209191-12-019665:0
- 14,534 sharesCommon StockSEC:0001209191-12-019665:1
- 158,439 sharesCommon StockSEC:0001209191-12-019665:2
- 3,162 sharesCommon StockSEC:0001209191-12-019665:3
- 391,478 shares@ US$13.00Common StockSEC:0001209191-12-019665:4Canonical exit: 19 Feb 2012 (T+90)
- 7,813 shares@ US$13.00Common StockSEC:0001209191-12-019665:5Canonical exit: 19 Feb 2012 (T+90)
- 16,525 shares0Common StockSEC:0001209191-10-061175:0
- 406,504 shares0Common StockSEC:0001209191-10-061175:1
- 337,831 sharesCommon StockSEC:0001104659-10-060752:6
- 593,697 sharesCommon StockSEC:0001104659-10-060752:7
- 95,788 sharesCommon StockSEC:0001104659-10-060752:8
- 99,645 sharesCommon StockSEC:0001104659-10-060752:9
- 12,966 sharesCommon StockSEC:0001104659-10-060752:0
- 13,478 sharesCommon StockSEC:0001104659-10-060752:1
- 23,688 sharesCommon StockSEC:0001104659-10-060752:2
- 3,821 sharesCommon StockSEC:0001104659-10-060752:3
25 of 31 declarations
